Posterior reversible encephalopathy syndrome (PRES/RPLS) during pulse steroid therapy in macrophage activation syndrome

Indian Journal of Pediatrics

Volumn 78, Issue 8, 2011, Pages 1002-1004

  Kumar, Sharath ^a   Rajam, L ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

JIA; Juvenile arthritis; Macrophage activation syndrome; MAS; Posterior reversible encephalopathy syndrome; PRES; RPLS; SoJIA

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CYCLOSPORIN; DEXAMETHASONE; ETOPOSIDE; FERRITIN; IMMUNOGLOBULIN; INOTROPIC AGENT; METHYLPREDNISOLONE; MIDAZOLAM; PHENYTOIN; PREDNISOLONE;

ALBUMIN BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CARDIOMEGALY; CASE REPORT; CHILD; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG PULSE THERAPY; ERYTHROCYTE SEDIMENTATION RATE; FERRITIN BLOOD LEVEL; FEVER; HEPATOMEGALY; HUMAN; JAUNDICE; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY DISEASE; LYMPHADENOPATHY; MACROPHAGE ACTIVATION SYNDROME; MALE; MYOCARDITIS; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRESCHOOL CHILD; RASH; SEIZURE; TACHYCARDIA; THROMBOCYTE COUNT; UREMIA;

CHILD; GLUCOCORTICOIDS; HUMANS; MACROPHAGE ACTIVATION SYNDROME; MALE; METHYLPREDNISOLONE; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PULSE THERAPY, DRUG;

EID: 79961167049     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-011-0368-2     Document Type: Article

References (8)

1. WS Bartynski 2008 Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features Am J Neuroradiol. 29 1036 42 18356474 10.3174/ajnr.A0928 1:STN:280:DC%2BD1cznsFSmsw%3D%3D (Pubitemid 351954863)
2. R Duncan D Hadley I Bone EM Symonds BS Worthington PC Rubin 1989 Blindness in eclampsia: CT and MR imaging J Neurol Neurosurg Psychiatry 52 899 902 2769284 10.1136/jnnp.52.7.899 1:STN:280:DyaL1MzmtFCrsw%3D%3D (Pubitemid 19181352)
3. RA Hauser DM Lacey MR Knight 1988 Hypertensive encephalopathy. Magnetic resonance imaging demonstration of reversible cortical and white matter lesions Arch Neurol. 45 1078 83 3178528 1:STN:280:DyaL1M%2FisFahtw%3D%3D
4. L Min J Zwerling LC Ocava IH Chen C Putterman 2006 Reversible posterior leukoencephalopathy in connective tissue diseases Semin Arthritis Rheum 35 388 95 16765716 10.1016/j.semarthrit.2006.01.003 (Pubitemid 43841894)
5. JI Henter A Horne M Arico, et al. 2007 HLH-2004:Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis Pediatr Blood Cancer 48 124 31 16937360 10.1002/pbc.21039 (Pubitemid 44958267)
6. C Mueller-Mang T Mang A Pirker K Klein C Prchla D Prayer 2009 Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology 51 373 83 19234694 10.1007/s00234-009-0504-0
7. C Roth A Ferbert 2010 Posterior reversible encephalopathy syndrome-long-term follow-up J Neurol Neurosurg Psychiatry 81 773 7 19955114 10.1136/jnnp.2009.189647
8. P Buddiga M Pedra-nobre H Jyonouchi A Wolff L Bielory 2005 Macrophage activation syndrome associated with posterior syndrome reversible encephalopathy J Allergy Clin Immunol 115 S17 10.1016/j.jaci.2004.12.085